Compounds > idrapril
Page last updated: 2024-08-24

idrapril and angiotensin ii

idrapril has been researched along with angiotensin ii in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunner, HR; Capone, P; Criscuoli, M; Nussberger, J; Zanchi, A1
Coppini, A; Criscuoli, M; Duranti, P; Favilla, S; Ghiadoni, L; Mattei, P; Romagnoli, A; Sudano, I; Taddei, S; Virdis, A1

Trials

2 trial(s) available for idrapril and angiotensin ii

ArticleYear
Angiotensin-converting enzyme inhibition by hydroxamic zinc-binding idrapril in humans.
    Journal of cardiovascular pharmacology, 1994, Volume: 24, Issue:2

    Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cyclohexanecarboxylic Acids; Double-Blind Method; Humans; Hydroxylamines; Male; Peptidyl-Dipeptidase A; Renin; Zinc

1994
Humoral and haemodynamic effects of idrapril calcium, the prototype of a new class of ACE-inhibitors, in essential hypertensive patients.
    European journal of clinical pharmacology, 1995, Volume: 48, Issue:5

    Topics: Absorption; Administration, Oral; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Cyclohexanecarboxylic Acids; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Hydroxylamines; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A

1995